Zobrazeno 1 - 10
of 330
pro vyhledávání: '"Ulrich M. Lauer"'
Autor:
Alban Piotrowsky, Markus Burkard, Katharina Hammerschmidt, Hannah K. Ruple, Pia Nonnenmacher, Monika Schumacher, Christian Leischner, Susanne Berchtold, Luigi Marongiu, Thomas A. Kufer, Ulrich M. Lauer, Olga Renner, Sascha Venturelli
Publikováno v:
Antioxidants, Vol 13, Iss 9, p 1095 (2024)
Several studies have demonstrated, both in vitro and in animal models, the anti-tumor efficacy of high-dose ascorbate treatment against a variety of tumor entities, including glioblastoma, the most common and aggressive primary malignant brain tumor.
Externí odkaz:
https://doaj.org/article/0e0ee2440fab426a82a3784ac1036db3
Autor:
Stavros Sotiriadis, Julia Beil, Susanne Berchtold, Irina Smirnow, Andrea Schenk, Ulrich M. Lauer
Publikováno v:
Viruses, Vol 16, Iss 5, p 775 (2024)
NUT (nuclear-protein-in-testis) carcinoma (NC) is a highly aggressive tumor disease. Given that current treatment regimens offer a median survival of six months only, it is likely that this type of tumor requires an extended multimodal treatment appr
Externí odkaz:
https://doaj.org/article/e41cbb98ceae47299878f08069ea5cbd
Autor:
Martina Hinterleitner, Ruben Pfeiffer, Nils F. Trautwein, Bence Sipos, Stephan Singer, Silvio Nadalin, Alfred Königsrainer, Ulrich M. Lauer, Christian la Fougère, Lars Zender, Clemens Hinterleitner
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
IntroductionNeuroendocrine neoplasms (NEN) are a rare and heterogenous group of tumors arising from neuroendocrine cells in multiple organs. Neuroendocrine tumors (NET) G3 encompass a small subgroup accounting for less than 10% of all neuroendocrine
Externí odkaz:
https://doaj.org/article/f776dfeedfdc46f3b01b72156cb56fc2
Autor:
Simon Heumos, Sandra Dehn, Konstantin Bräutigam, Marius C. Codrea, Christian M. Schürch, Ulrich M. Lauer, Sven Nahnsen, Michael Schindler
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Immunotherapy with immune checkpoint inhibitors (ICI) has revolutionized cancer therapy. However, therapeutic targeting of inhibitory T cell receptors such as PD-1 not only initiates a broad immune response against tumors, but als
Externí odkaz:
https://doaj.org/article/8bb11c41994743a69f5a8ec609156a24
Autor:
Martina S. Lutz, Latifa Zekri, Laura Weßling, Susanne Berchtold, Jonas S. Heitmann, Ulrich M. Lauer, Gundram Jung, Helmut R. Salih
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
T cell-based immunotherapy has significantly improved treatment options for many malignancies. However, despite these and other therapeutic improvements over the last decades, gastrointestinal cancers, in particular pancreatic, hepatic and gastric ca
Externí odkaz:
https://doaj.org/article/a9c1d07ea6db491a89f09555d59e60dd
Autor:
Lara M. Khoury, Kimberly M. Burcher, Ronald T. Ng, Alexander H. Song, Mark J. Chang, Elena Gavrila, Chance H. Bloomer, Mac B. Robinson, Brian E. Kouri, Joshua D. Waltonen, Paul M. Bunch, Ulrich M. Lauer, Mercedes Porosnicu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Immune checkpoint inhibitors (ICIs) are the current guideline recommended treatment for many malignancies considered to be terminal. Despite considerable advances, their utility remains limited, and the field requires synergistic partners to further
Externí odkaz:
https://doaj.org/article/483654dff18f4ed9bb6231e345b4dea5
Autor:
Linus D. Kloker, Branko Calukovic, Katrin Benzler, Alexander Golf, Sebastian Böhm, Sven Günther, Marius Horger, Simone Haas, Susanne Berchtold, Julia Beil, Mary E. Carter, Tina Ganzenmueller, Stephan Singer, Abbas Agaimy, Robert Stöhr, Arndt Hartmann, Thomas Duell, Sandra Mairhofer, Fabian Fohrer, Niels Reinmuth, Lars Zender, Ulrich M. Lauer
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
NUT carcinoma (NC) is a rare and extremely aggressive form of cancer, usually presenting with intrathoracic or neck manifestations in adolescents and young adults. With no established standard therapy regimen and a median overall survival of only 6.5
Externí odkaz:
https://doaj.org/article/937409fb0e814f379cae06b3619b90ce
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
The use of phages as antibacterials is becoming more and more common in Western countries. However, a successful phage-derived antibacterial treatment needs to account for additional features such as the loss of infective virions and the multiplicati
Externí odkaz:
https://doaj.org/article/3ac786e08c5f4022b8e72e8232d8a316
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis and a median survival of 6–9 months only. Although very few cases of NC are reported each year, the true prevalence is estimated to be much higher, with NC potent
Externí odkaz:
https://doaj.org/article/39734a5c312b4e5fbec029ccd60ad515
Autor:
Mattia Sirgiovanni, Clemens Hinterleitner, Marius Horger, Naushad Bijoy Atique, Ulrich M. Lauer, Lars Zender, Martina Hinterleitner
Publikováno v:
Thoracic Cancer, Vol 12, Iss 5, Pp 699-702 (2021)
Abstract Immune‐checkpoint inhibitors (ICIs) provide a promising treatment option for advanced tumors including small cell lung cancer (SCLC). Nevertheless, in addition to immune‐related adverse events (irAEs), an increased risk of infection incl
Externí odkaz:
https://doaj.org/article/2c156fed30e849c2961ad2aac761a37e